David Milne

David Milne has extensive experience in various leadership positions and advisory roles within the healthcare and life sciences industry. David currently serves as the Chairman of the Board at Asensus Surgical, a position they have held since 2014. In addition, they are the Chairman of the Board at OneProjects, where they are involved in developing catheter-based intracardiac ultrasound technologies.

David has also served as a CEO Advisor at Tixologi, Petastic - The Pet Data Company, and Rogers Sciences, Inc., providing guidance and expertise in their respective fields. Prior to these roles, they spent over 14 years as the Managing Partner at SV Healthcare Investors, LLC, a prominent healthcare and life sciences venture capital firm. During their tenure, they raised over $2.9 billion in capital commitments across multiple funds.

Furthermore, David has served on the boards of various healthcare companies, including Entellus Medical, Inc. (acquired by Stryker), Spinal Kinetics (acquired by Orthofix), and Altura Medical Inc. (acquired by Endologix). These experiences have allowed him to contribute valuable insights and strategic direction to these organizations.

David's contributions extend beyond the business realm, as they have also served as a Board Member at Friends of the Children, a non-profit organization dedicated to helping vulnerable youth.

Overall, David Milne's work experience reflects their deep involvement and expertise in the healthcare and life sciences industry, encompassing leadership roles, advisory positions, and board memberships.

David Milne completed their Bachelor of Science degree in Biochemistry from Rutgers University, from 1980 to 1984. David later pursued a Master of Business Administration (MBA) degree with a focus on Marketing from NYU Stern School of Business, between 1987 and 1989.